Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.
about
Conjugate vaccines for preventing meningococcal C meningitis and septicaemiaConjugate vaccines for preventing meningococcal C meningitis and septicaemiaProspects for vaccine prevention of meningococcal infectionImmunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccineKinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagersUpdated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunityEvaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial.Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.Impact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy.Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4.Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccineInfluence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000.Priming for immunologic memory in adults by meningococcal group C conjugate vaccination.Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults.Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?The immunopathogenesis of meningococcal disease.Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.Meningococcal conjugate vaccines: optimizing global impact.Critical analysis of old and new vaccines against N. meningitidis serogroup C, considering the meningococcal disease epidemiology in Brazil.Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.Serologic correlates of protection for evaluating the response to meningococcal vaccines.Human Infant Memory B Cell and CD4+ T Cell Responses to HibMenCY-TT Glyco-Conjugate Vaccine.Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvantSafety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in EnglandImmunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children.Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals.Towards an improved serogroup B Neisseria meningitidis vaccine.Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children.Immunization strategies for the control of serogroup C meningococcal disease in developed countries.Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012
P2860
Q24235722-C4998489-DD40-4773-A5E1-E27BF7DD690EQ24244951-022D4AB4-BD6D-4C15-AFF6-15AA45137CF0Q24537338-7188186E-9E77-46A3-AAE0-0CF3C5E1783AQ28749695-9DFB1837-C374-48F3-9B83-D725D7D95D5BQ33557154-50491AD0-486F-4311-8A3D-7E0432588346Q33806774-40A5A021-DE18-4D73-BCAC-88E69C13BE16Q33825722-9453C414-96D8-4CD7-BCC9-5022A3793471Q33895627-5E6DCE23-65FF-4A19-A1B6-474AA875B538Q34006352-986E1380-1C70-42B3-9632-681E7960A7A9Q34006865-134A734A-6BD7-428F-8233-7ECE0F913285Q34033849-F8D29812-2ECF-4E17-8768-8BA7C9900AF1Q34064278-B9C9014D-3089-458F-8570-3AFE6799B089Q34118124-B68743F5-33CD-47BF-A95D-210BAD677098Q34131154-376805C0-8F00-4A8A-93FD-0D4D3CF790B8Q34170021-998A100C-05CF-4B12-8E53-5CDE90ABA1A2Q34480575-D5569D78-C786-4D39-9FB1-A696A5D976F8Q34618444-13D33288-06E0-42D4-BAB7-11CF5383E99BQ34720293-72FCECA7-3E92-420F-9C9A-76286C9B22C5Q34738958-3DF9D109-9E77-491A-B90B-D4A7BC309224Q34975007-39EC9375-2F38-4958-8AAE-C7599E458A3BQ35144175-743F2759-84C9-46C1-98D5-22F5736CA220Q35542416-7F7A0E9F-4614-4045-891A-0A5577484218Q35547767-C4C18F24-3684-4786-998E-BC34C61DAA29Q35554452-C7E91F4C-A79C-4649-8235-09CD630D1459Q35588006-F69BA904-2176-44F0-9DBD-E7DF5330053BQ35648260-C55F58F9-FDCB-45D4-8073-CDCF2AB4BA1AQ35697891-905D79E0-5FDF-4CD1-92FB-35BD2CDA4192Q35783483-DC7209F4-2530-453F-A645-353377A3D697Q35783606-519EDFF2-E731-4920-A497-EE5E5D1A04D8Q35887397-D51AC757-955C-4CEF-93EE-839425457626Q35887417-0C8E4F2F-CC2D-4A56-BA46-36CC9496A92FQ35920353-A7B001CF-96A1-4813-BA93-AE7DC4F85A47Q35923728-2B5D4A5E-E752-4495-A023-D2C31C0CFE25Q36045855-70015E1E-A13F-48E2-9F8C-C62BF759271FQ36153370-90B37688-01F8-4C69-A15E-AE0F1D07ABE2Q36228084-1FC6A71D-DF1C-49DA-8991-5A291F9AF8F2Q36327065-BDA88D9B-9879-4AD1-9343-B7FDFCA00FDAQ36391874-81634B51-D2AA-41FE-B540-DC0AB98E41CDQ36445558-F7D25586-D897-4A83-89A9-EEDF7EF39963Q36478305-0F1977F7-0825-4A24-A3E1-77D14F81BABC
P2860
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Ability of 3 different meningo ...... a single dose in UK toddlers.
@en
Ability of 3 different meningo ...... a single dose in UK toddlers.
@nl
type
label
Ability of 3 different meningo ...... a single dose in UK toddlers.
@en
Ability of 3 different meningo ...... a single dose in UK toddlers.
@nl
prefLabel
Ability of 3 different meningo ...... a single dose in UK toddlers.
@en
Ability of 3 different meningo ...... a single dose in UK toddlers.
@nl
P2093
P356
P1476
Ability of 3 different meningo ...... r a single dose in UK toddlers
@en
P2093
D Goldblatt
K Cartwright
P304
P356
10.1086/317646
P407
P577
2000-11-14T00:00:00Z